|4Dec 19, 5:10 PM ET

ACHILLION PHARMACEUTICALS INC 4

4 · ACHILLION PHARMACEUTICALS INC · Filed Dec 19, 2013

Insider Transaction Report

Form 4
Period: 2013-12-17
Apelian David
EVP and Chief Medical Officer
Transactions
  • Award

    Employee Stock Option(Right to Buy)

    2013-12-17300,000300,000 total
    Exercise: $3.02Exp: 2023-12-17Common Stock (300,000 underlying)
Footnotes (1)
  • [F1]This option grant vests as to 25% of the shares on the first anniversary of the date of grant and as to an additional 6.25% at the end of each three month period thereafter.

Documents

1 file
  • 4
    rrd398059.xmlPrimary

    APELIAN FORM 4 ANNUAL GRANT